EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Upregulation of Hepatic Glutathione S-Transferase Alpha 1 Ameliorates Metabolic Dysfunction-Associated Steatosis by Degrading Fatty Acid Binding Protein 1

Jing Jiang, Hu Li, Mei Tang, Lei Lei, Hong-Ying Li, Biao Dong, Jian-Rui Li, Xue-Kai Wang iD, Han Sun, Jia-Yu Li, Jing-Chen Xu, Yue Gong und 2 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25105086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jing Jiang und 13 weiteren Autor:innen. Beteiligte Einrichtung: CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical Coll…. Hauptthemen laut MEDLINE: Glutathione Transferase, Fatty Acid-Binding Proteins, Fatty Liver, Up-Regulation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Mega-Project for "R&D for Innovative drugs", Ministry of Science and Technology, CAMS Innovation Fund for Medical Sciences, National Natural Science Foundation, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common metabolic disease of the liver, characterized by hepatic steatosis in more than 5% of hepatocytes. However, despite the recent approval of the first drug, resmetirom, for the management of metabolic dysfunction-associated steatohepatitis, decades of target exploration and hundreds of clinical trials have failed, highlighting the urgent need to find new druggable targets for the discovery of innovative drug candidates against MASLD. Here, we found that glutathione S-transferase alpha 1 (GSTA1) expression was negatively associated with lipid droplet accumulation in vitro and in vivo. Overexpression of GSTA1 significantly attenuated oleic acid-induced steatosis in hepatocytes or high-fat diet-induced steatosis in the mouse liver. The hepatoprotective and anti-inflammatory drug bicyclol also attenuated steatosis by upregulating GSTA1 expression. A detailed mechanism showed that GSTA1 directly interacts with fatty acid binding protein 1 (FABP1) and facilitates the degradation of FABP1, thereby inhibiting intracellular triglyceride synthesis by impeding the uptake and transportation of free fatty acids. Conclusion: GSTA1 may be a good target for the discovery of innovative drug candidates as GSTA1 stabilizers or enhancers against MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glutathione TransferaseFatty Acid-Binding ProteinsFatty LiverUp-RegulationAnimalsHumansMiceLiverDiet, High-FatMaleMice, Inbred C57BLHepatocytesLipid MetabolismOleic AcidHep G2 CellsTriglyceridesIsoenzymes

Stichwörter der Autor:innen

bicycloldrug targetfatty acid binding protein 1glutathione S-transferase alpha 1hepatic steatosis

Substanzen

Glutathione TransferaseFatty Acid-Binding ProteinsGSTA1 protein, humanOleic AcidTriglyceridesFABP1 protein, humanglutathione S-transferase alphaIsoenzymes

Autor:innen und Institutionen

  • CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
  • Key Laboratory of Biotechnology of Antibiotics, The National Health and Family Planning Commission (NHFPC), Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beiji…
  • Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.

ORCID-Profile: Xue-Kai Wang

Förderung

  • National Mega-Project for "R&D for Innovative drugs", Ministry of Science and Technology
  • CAMS Innovation Fund for Medical Sciences
  • National Natural Science Foundation, China
  • National Mega-Project for “R&D for Innovative drugs”, Ministry of Science and Technology, China

Zitieren

APA

Jiang, J., Li, H., Tang, M., Lei, L., Li, H. Y., Dong, B., Li, J. R., Wang, X. K., Sun, H., Li, J. Y., Xu, J. C., Gong, Y., Jiang, J. D., & Peng, Z. G. (2024). Upregulation of Hepatic Glutathione S-Transferase Alpha 1 Ameliorates Metabolic Dysfunction-Associated Steatosis by Degrading Fatty Acid Binding Protein 1. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105086

Vancouver

Jiang J, Li H, Tang M, Lei L, Li HY, Dong B, et al. Upregulation of Hepatic Glutathione S-Transferase Alpha 1 Ameliorates Metabolic Dysfunction-Associated Steatosis by Degrading Fatty Acid Binding Protein 1. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105086

BibTeX
@article{Jiang2024,
  author = {Jiang, Jing and Li, Hu and Tang, Mei and Lei, Lei and Li, Hong-Ying and Dong, Biao and Li, Jian-Rui and Wang, Xue-Kai and Sun, Han and Li, Jia-Yu and Xu, Jing-Chen and Gong, Yue and Jiang, Jian-Dong and Peng, Zong-Gen},
  title = {Upregulation of Hepatic Glutathione S-Transferase Alpha 1 Ameliorates Metabolic Dysfunction-Associated Steatosis by Degrading Fatty Acid Binding Protein 1},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25105086}
}
Kostenlos starten →